#AbbVie successor to #Humira in #psoriasis gains #FDA approval https://t.co/FQhq9Mrkfl @BioCentury @abbvie #biosimilar #Skyrizi $ABBV
#AbbVie successor to #Humira in #psoriasis gains #FDA approval https://t.co/FQhq9Mrkfl @BioCentury @abbvie #biosimilar #Skyrizi $ABBV